The Pharma Data

DECEMBER 28, 2020

Centers for Disease Control and Prevention said Saturday. The test is needed to guard against the spread of a new form of the virus found in the U.K. However, a new virus variant that has been spreading around London and southern England has now been spotted in France, Italy, Spain, Canada and Japan. © 2020 HealthDay.

Vaccine 52

Vaccine Virus Nurses Science 52

Codon

AUGUST 26, 2024

When COVID-19 emerged in 2019, by contrast, mRNA vaccines developed by Pfizer and Moderna took just 326 days from the initial sequencing of the virus to gaining approval for emergency use. These drugs would be ideal tools to bridge the wait for a vaccine against a quickly-spreading virus.

RNA 93

RNA Virus DNA Vaccine 93

Drug Discovery World

OCTOBER 12, 2023

Dr Samulski has advanced therapeutics into human clinical trials for haemophilia, Duchenne muscular dystrophy, giant axonal neuropathy, Pompe disease and heart failure. He co-founded AskBio in 2001 and in October 2020, Bayer acquired AskBio for $4 billion. He holds more than 200 patents related to AAV technology.

Therapies 130

Therapies FDA Approval Clinical Trials Virus 130

The Pharma Data

DECEMBER 2, 2020

Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. © 2020 HealthDay. Posted: December 2020. Below are newsworthy items compiled by the Healthday staff: CDC To Shorten Recommended Quarantine Period. The antibodies suggest exposure to the new coronavirus or one very similar to it.

Virus 52

Virus Disease Research 52

Broad Institute

APRIL 25, 2024

He started to imagine how the deadly and contagious disease, if confirmed, might spread to half the city’s population. Eight of the 20 patients died, but the spread of the disease in Nigeria stopped there. Blood and urine samples from the man were waiting for Happi in his lab. Happi felt chilled. They called the idea Sentinel.

Virus 132

Virus Hospitals Disease Government 132

The Pharma Data

AUGUST 3, 2021

The drug, which has undergone several clinical trials for human conditions but has not yet received approval to treat humans, inhibited the replication of SARS-CoV-2, the virus that causes COVID-19, in human cell cultures and in a mouse model, leading to much lower viral loads. The research team, including scientists from the U.S.

Virus 52

Virus Clinical Trials Drugs Laboratories 52

The Pharma Data

SEPTEMBER 4, 2020

The main test used to diagnose coronavirus is so sensitive it could be picking up fragments of dead virus from old infections, scientists say. He believes the detection of traces of old virus could partly explain why the number of cases is rising while hospital admissions remain stable. Image copyright. Getty Images.

Virus 52

Virus Hospitals Disease Research 52

The Pharma Data

DECEMBER 29, 2020

Experts believe brain-related effects may be tied to the body’s immune response to the virus and possibly to vascular problems or surges of inflammation caused by the disease. WHO is working with scientists around the world to “better understand any and all changes to the virus” and their impact, he said.

Virus 52

Virus Hospitals Immune Response Doctors 52

The Pharma Data

DECEMBER 21, 2020

The team at the Walter Reed Army Institute of Research is checking genetic sequences of the mutated virus variant posted online by British researchers, CNN reported. Centers for Disease Control and Prevention. © 2020 HealthDay. Posted: December 2020. The CDC said more than 190.4 million doses to 45.3 million as of Nov.

Packaging 52

Packaging Vaccine Laboratories Virus 52

The Pharma Data

MARCH 13, 2022

People who gained immunity – either through vaccination or exposure – against the original strain of SARS-CoV-2, the virus that causes COVID-19, also are likely to have some protection against the pathogen’s omicron variant. Singapore biotechnology company. population.

Virus 52

Virus Immune Response Vaccine Research 52

The Pharma Data

NOVEMBER 18, 2020

Antimicrobial resistance occurs when microorganisms resist the effects of medications, making infections harder to treat and increasing the risk of disease spread, severe illness and death. HIV drug resistance is caused by changes in the genetic structure of HIV that affects the ability of drugs to block the replication of the virus.

Laboratories 52

Laboratories Virus Government Therapies 52

Drug Discovery World

NOVEMBER 30, 2022

million to support further development of the re-engineered technology for use in the global response to future disease outbreaks. . Importantly, this re-engineered technology does not pose any issue with diagnostic interference as was encountered in 2020.” . Clamp technology .

Vaccine 130

Vaccine Immune Response Virus Engineering 130

Drug Discovery World

OCTOBER 18, 2023

Sara Donnelly, Director of Research Planning and Business Development at PhoenixBio USA explores why the right pre-clinical model is essential for teams wanting to advance adeno-associated virus vector-based gene therapies. Adeno-associated virus (AAV) vector-based gene therapies hold exceptional promise across a range of disease areas.

Therapies 162

Therapies Clinical Trials FDA Approval Virus 162

Drug Discovery World

AUGUST 2, 2022

an estimated 270,000 people were diagnosed with a primary brain tumor in 2020, with a five-year survival rate of only 5%. Despite their potential, the first-generation oncolytic virus therapies given as free virus were not very effective — most likely due to rapid inactivation by the patient’s immune system. survival of ?less

Trials 130

Trials FDA Immune Response Clinical Trials 130

Drug Discovery World

AUGUST 16, 2022

1) and the original 2020 strain 1. . 1 variant as well as the original 2020 strain. . The first generation of Covid-19 vaccines being used in the UK continue to provide important protection against the disease and save lives.

Immune Response 130

Immune Response Vaccine Clinical Trials Virus 130

The Pharma Data

NOVEMBER 17, 2020

17, 2020 — From 2009 to 2018, there were increases in diseases-of-despair diagnoses, according to a study published online Nov. Diagnoses related to alcohol misuse, substance misuse, and suicide ideation/behaviors were defined as diseases of despair. © 2020 HealthDay. Posted: November 2020. TUESDAY, Nov.

Disease 52

Disease Virus Research Drugs 52

The Pharma Data

DECEMBER 30, 2020

The year 2020 will certainly go down in history as the year of COVID-19. Gilead Sciences Makes Multiple Bets : When Gilead Sciences wasn’t working on remdesivir in COVID-19, the company seemed to be constantly flexing its M&A muscle over the course of 2020. It began in May with the $4.9

Science 52

Science Pharmaceuticals Disease FDA Approval 52

Drug Discovery World

FEBRUARY 28, 2024

” Ovarian cancer breakthrough According the World Cancer Research Fund International, ovarian cancer is the eighth most common cancer in women worldwide and there were more than 313,000 new cases of this disease in 2020. Research into new cancer drugs remain strong. .”

Drug Development 162

Drug Development Research Clinical Trials Drugs 162

The Pharma Data

MARCH 24, 2021

Strong R&D commitment to developing therapeutics against SARS-CoV-2 virus. billion EUR in 2020 (18.9% Boehringer Ingelheim stepped up its investments in R&D significantly in 2020 in pursuit of innovative medicines and therapies for diseases for which no satisfactory treatments are available. of net sales).

Vaccine 52

Vaccine Small Molecule Therapies Disease 52

Drug Target Review

AUGUST 11, 2023

In a new development, a recent paper published in Biology Methods & Protocols by Oxford University Press has highlighted a promising avenue for enhancing vaccine efficacy against infectious pathogens like the COVID-19 virus. Since December 2019, SARS-CoV-2 (COVID-19) infection has become a worldwide urgent public health concern.

Vaccine 98

Vaccine Immune Response Bioinformatics Virus 98

The Pharma Data

JULY 23, 2021

Results from the Canadian Immunization Research Network (CIRN) with support from Public Health Agency of Canada and the Canadian Institutes of Health Research, published as a pre-print , demonstrated one dose of Vaxzevria was 82% effective against hospitalisation or death caused by the Beta/Gamma variants of the SARS-CoV-2 virus.

Disease 52

Disease Virus Vaccine Trials 52

The Pharma Data

NOVEMBER 3, 2020

Centers for Disease Control and Prevention study collected data on more than 400,000 symptomatic women aged 15 to 44, of whom more than 23,000 were pregnant. ” Prime Minister Boris Johnson also had the virus in the spring. © 2020 HealthDay. Posted: November 2020. He was admitted to the hospital, but recovered.

Hospitals 52

Hospitals Doctors Laboratories Virus 52

The Pharma Data

MAY 15, 2023

CHMP Adopts Positive Opinion Recommending Hepcludex® (Bulevirtide) for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus (HDV) Gilead Sciences, Inc. Bulevirtide was initially granted conditional marketing authorisation in July 2020 to provide people living with HDV urgent access to treatment. In the U.S.

Virus 40

Virus Marketing Treatment Medical Schools 40

The Pharma Data

DECEMBER 25, 2020

26, 2020 /CNW/ – The Government of Canada has a monitoring program in place with the provinces and territories to identify new COVID-19 variants in Canada , such as the ones identified in the United Kingdom and South Africa. OTTAWA, ON , Dec.

Virus 52

Virus Compliance Government Laboratories 52

The Pharma Data

DECEMBER 5, 2020

5, 2020 — A pair of new gene therapies promise a potentially lasting cure for sickle cell disease by subtly altering the genetic information in patients’ bone marrow cells, researchers report. Lewis Hsu, chief medical officer of the Sickle Cell Disease Association of America. SATURDAY, Dec.

Therapies 52

Therapies Disease Medical Schools Virus 52

The Pharma Data

APRIL 14, 2021

The product’s early Marek’s disease onset of immunity from five days of age provides full protection of broilers, layers and breeders against the most virulent Marek’s disease virus strains. Its purpose is to provide poultry producers with cutting-edge technology in terms of Marek’s disease protection.

Vaccine 52

Vaccine Disease Virus Engineering 52

The Pharma Data

OCTOBER 26, 2020

27, 2020 10:45 UTC. –( BUSINESS WIRE )– Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2020. 2020. for the third quarter of 2020. . for the third quarter of 2020. KENILWORTH, N.J.–(

Vaccine 40

Vaccine Trials Licensing Licensing 40

The Pharma Data

JUNE 28, 2021

Parkinson’s disease is most common neurodegenerative movement disorder / It impacts more than 10 million people worldwide/ No function-restoring therapy is currently available / Bayer is pursuing a two-pronged approach to deliver transformative therapies with one cell and one gene therapy candidate in clinical trials.

Therapies 52

Therapies Disease Clinical Trials Trials 52

Drug Target Review

OCTOBER 26, 2023

1 Adeno-associated virus (AAV) vectors are the leading platform for in vivo gene delivery for the treatment of various human diseases. It has been well established that exposure to wild-type AAV results in priming of the immune system against the virus. Nature 578 , 229-236 (2020). References Doudna JA. Ylä-Herttuala S.

Engineering 105

Engineering Virus Therapies Immune Response 105

The Pharma Data

NOVEMBER 5, 2020

5, 2020 /PRNewswire/ — Third quarter 2020 revenues increased 32% to $2.29 Third quarter 2020 EYLEA ® U.S. Third quarter 2020 Dupixent ® global net sales (2) , which are recorded by Sanofi, increased 69% to $1.07 Third quarter 2020 Dupixent ® global net sales (2) , which are recorded by Sanofi, increased 69% to $1.07

Production 52

Production FDA FDA Approval Trials 52

The Pharma Data

DECEMBER 10, 2020

The FDA said Thursday that it has developed a test for COVID-19 in fecal matter, in an attempt to prevent the disease from being inadvertently transmitted during fecal transplantation. We know now that the viral RNA is found in stool and infectious virus as well. 1, 2019, until effective screening methods are implemented.”.

FDA 52

FDA Laboratories RNA Virus 52

The Pharma Data

DECEMBER 9, 2020

10, 2020 04:32 UTC. The offering is expected to close on or about December 14, 2020, subject to satisfaction of customary closing conditions. The company’s platform-agnostic approach enables it to design the best therapy for each indication, creating potentially transformative options for patients afflicted with rare genetic diseases.

Pharmaceuticals 40

Pharmaceuticals Clinical Trials Therapies Trials 40

The Pharma Data

JULY 21, 2021

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, and Pfizer Inc. Valneva and Pfizer entered into a collaboration agreement in April 2020 to co-develop VLA15 2. About VLA15.

Vaccine 52

Vaccine Disease Trials Protein Expression 52

Drug Target Review

JULY 19, 2023

Most vaccines cannot be self-administered, so distribution requires access to trained healthcare services – a big problem in developing countries, which is where infectious disease burdens are highest. A leading company in this field, Seattle’s Lumen Bioscience, is best known for its orally delivered antibodies targeting diseases such as C.

Vaccine 96

Vaccine Engineering Disease Virus 96

NIH Director's Blog: Drug Development

MARCH 18, 2021

With support from a 2020 NIH Director’s Pioneer Award, Veesler will study members of the order Chiroptera. These days, the Veesler lab has been hard at work to understand SARS-CoV-2 and the human immune response to the virus. 2020 Apr 16;181(2):281-292.e6. Or, more colloquially, bats. Veesler says bats are remarkable creatures.

Virus 52

Virus Immune Response Clinical Trials Vaccine 52

The Pharma Data

OCTOBER 31, 2020

Since the first cases were reported in March 2020 , there have been 234,511 cases of COVID-19, including 10,136 deaths reported in Canada ; these cumulative numbers tell us about the overall burden of COVID-19 illness to date. OTTAWA, ON , Nov. The number of people experiencing severe illness continues to increase.

Assisted Living 40

Assisted Living Hospitals Laboratories Disease 40

The Pharma Data

NOVEMBER 6, 2020

6, 2020 — As the daily U.S. universities reopened their campuses to students in some capacity this fall, the newspaper said, and some schools have appeared to keep the virus in check, primarily through extensive testing programs. © 2020 HealthDay. Posted: November 2020. FRIDAY, Nov. More than a third of U.S.

Virus 40

Virus Vaccine Government Doctors 40